Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) has shared an announcement.
Shanghai Junshi Biosciences Co., Ltd. announced the return of idle proceeds previously used for temporary liquidity replenishment. The funds, amounting to no more than RMB2 billion, were utilized for business expansion and daily operations, with a commitment to return them to the special account as per the investment project’s needs. This move reflects the company’s strategic management of resources to support its core business activities.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a joint stock company based in China, operating in the biotechnology industry. The company focuses on the development and commercialization of innovative therapies, particularly in the field of immuno-oncology.
YTD Price Performance: 25.22%
Average Trading Volume: 1,565,041
Technical Sentiment Signal: Hold
Current Market Cap: HK$27.27B
For a thorough assessment of 1877 stock, go to TipRanks’ Stock Analysis page.